Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roxana S Redis

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Molecular & Cellular Oncology|September 22, 2016
The interplay between lnRNAs, SNPs, and protein complexes - what does it mean for cancer metabolism?Roxana S Redis, George A Calin
Journal of Cellular Biochemistry|January 4, 2012
Non-coding RNAs as theranostics in human cancersRoxana S Redis, Ioana Berindan-Neagoe, Victor I Pop, et al.
Pharmacology & Therapeutics|August 21, 2012
Cell-to-cell miRNA transfer: from body homeostasis to therapyRoxana S Redis, Steliana Calin, Yaling Yang, et al.
Expert Opinion on Drug Discovery|November 21, 2022
RNA-based drug discovery for spinal muscular atrophy: a story of small molecules and antisense oligonucleotidesBlanca Torroba, Natsuko Macabuag, Elisabeth M Haisma, et al.
Oncotarget|July 1, 2016
Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinomaJinmai Jiang, Ana Clara P Azevedo-Pouly, Roxana S Redis, et al.
Cell Discovery|September 15, 2017
Regulation of hnRNPA1 by microRNAs controls the miR-18a-<i>K-RAS</i> axis in chemotherapy-resistant ovarian cancerCristian Rodriguez-Aguayo, Paloma Del C Monroig, Roxana S Redis, et al.
Cell Discovery|November 8, 2023
Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancerCristian Rodriguez-Aguayo, Paloma Del C Monroig, Roxana S Redis, et al.
Oncotarget|October 1, 2013
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlationsRoxana S Redis, Anieta M Sieuwerts, Maxime P Look, et al.
Scientific Reports|September 1, 2018
OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancersPaloma Del C Monroig-Bosque, Maitri Y Shah, Xiao Fu, et al.
JCI Insight|January 17, 2020
miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2Enrique Fuentes-Mattei, Recep Bayraktar, Taghi Manshouri, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Molecular & Cellular Oncology|September 22, 2016
The interplay between lnRNAs, SNPs, and protein complexes - what does it mean for cancer metabolism?Roxana S Redis, George A Calin
Journal of Cellular Biochemistry|January 4, 2012
Non-coding RNAs as theranostics in human cancersRoxana S Redis, Ioana Berindan-Neagoe, Victor I Pop, et al.
Pharmacology & Therapeutics|August 21, 2012
Cell-to-cell miRNA transfer: from body homeostasis to therapyRoxana S Redis, Steliana Calin, Yaling Yang, et al.
Expert Opinion on Drug Discovery|November 21, 2022
RNA-based drug discovery for spinal muscular atrophy: a story of small molecules and antisense oligonucleotidesBlanca Torroba, Natsuko Macabuag, Elisabeth M Haisma, et al.
Oncotarget|July 1, 2016
Globally increased ultraconserved noncoding RNA expression in pancreatic adenocarcinomaJinmai Jiang, Ana Clara P Azevedo-Pouly, Roxana S Redis, et al.
Cell Discovery|September 15, 2017
Regulation of hnRNPA1 by microRNAs controls the miR-18a-<i>K-RAS</i> axis in chemotherapy-resistant ovarian cancerCristian Rodriguez-Aguayo, Paloma Del C Monroig, Roxana S Redis, et al.
Cell Discovery|November 8, 2023
Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancerCristian Rodriguez-Aguayo, Paloma Del C Monroig, Roxana S Redis, et al.
Oncotarget|October 1, 2013
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlationsRoxana S Redis, Anieta M Sieuwerts, Maxime P Look, et al.
Scientific Reports|September 1, 2018
OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancersPaloma Del C Monroig-Bosque, Maitri Y Shah, Xiao Fu, et al.
JCI Insight|January 17, 2020
miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2Enrique Fuentes-Mattei, Recep Bayraktar, Taghi Manshouri, et al.
Pageof 2